XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) based upon the job functions of the employees receiving the grants.  Compensation expense related to EOG's stock-based compensation plans for the years ended December 31, 2021, 2020 and 2019 was as follows (in millions):
 202120202019
Lease and Well$49 $52 $56 
Gathering and Processing Costs3 1 1 
Exploration Costs20 21 26 
General and Administrative80 72 92 
Total$152 $146 $175 
Vesting Schedule
The vesting schedules for grants of stock options, SARs, restricted stock and restricted stock units, and Performance Units are generally as follows:
Grant TypeVesting Schedule
Stock Options/SARsVesting in increments of one-third on each of the first three anniversaries, respectively, of the date of grant
Restricted Stock/Restricted Stock Units"Cliff" vesting three years from the date of grant
Performance Units
"Cliff" vesting on the February 28th following the three-year performance period and the Compensation and Human Resources Committee's certification of the applicable performance multiple
Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants for the years ended December 31, 2021, 2020 and 2019 were as follows:
 Stock Options/SARsESPP
 202120202019202120202019
Weighted Average Fair Value of Grants
$24.92 $11.06 $19.49 $18.12 $19.14 $22.83 
Expected Volatility42.24 %44.47 %32.02 %51.27 %53.48 %34.78 %
Risk-Free Interest Rate0.50 %0.21 %1.69 %0.07 %0.90 %2.27 %
Dividend Yield2.26 %3.27 %1.39 %2.89 %2.27 %1.04 %
Expected Life5.2 years5.2 years5.1 years0.5 years0.5 years0.5 years
Schedule of Share Based Compensation Arrangement By Share Based Payment Award
The following table sets forth the stock option and SAR transactions for the years ended December 31, 2021, 2020 and 2019 (stock options and SARs in thousands):
 202120202019
 Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price
Outstanding at January 110,186 $84.08 9,395 $94.53 8,310 $96.90 
Granted1,982 81.68 1,996 37.63 1,965 75.39 
Exercised (1)
(1,130)63.98 (23)69.59 (606)61.43 
Forfeited(1,069)98.15 (1,182)88.93 (274)102.57 
Outstanding at December 319,969 84.37 10,186 84.08 9,395 94.53 
Stock Options/SARs Exercisable at December 31
6,197 95.33 6,343 96.41 5,275 94.21 
(1)The total intrinsic value of stock options/SARs exercised during the years 2021, 2020 and 2019 was $27 million, $0.4 million and $14 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
Stock Options and SARs Outstanding and Exercisable
The following table summarizes certain information for the stock options and SARs outstanding and exercisable at December 31, 2021 (stock options and SARs in thousands):
Stock Options/SARs OutstandingStock Options/SARs Exercisable
Range of
Grant
Prices		Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value(1)
Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value (1)
$ 34.00 to $  52.991,640 6$37.50  414 5$37.46   
53.00 to     75.991,906 473.68  1,313 373.11   
   76.00 to     90.991,976 781.86  33 283.71   
   91.00 to     95.991,114 294.95  1,109 294.96   
   96.00 to   101.991,657 396.34  1,652 396.33   
 102.00 to   129.991,676 4126.51 1,676 4126.51 
 9,969 484.37 $127 6,197 395.33 $42 
(1)Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs, in millions.
ESPP Activity The following table summarizes ESPP activity for the years ended December 31, 2021, 2020 and 2019 (in thousands, except number of participants):
 202120202019
Approximate Number of Participants2,036 2,063 1,998 
Shares Purchased316 377 224 
Aggregate Purchase Price$17,224 $16,103 $16,533 
Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth the restricted stock and restricted stock unit transactions for the years ended December 31, 2021, 2020 and 2019 (shares and units in thousands):
 202120202019
 Number of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair Value
Outstanding at January 14,742 $74.97 4,546 $90.16 3,792 $96.64 
Granted1,422 81.50 1,488 38.10 1,749 80.01 
Released (1)
(1,388)101.00 (1,213)85.92 (855)96.93 
Forfeited(96)68.26 (79)86.52 (140)97.54 
Outstanding at December 31 (2)
4,680 69.37 4,742 74.97 4,546 90.16 
(1)
(1)The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2021, 2020 and 2019 was $110 million, $48 million and $70 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
(2)
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2021, 2020 and 2019 was $416 million, $236 million and $381 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
Weighted Average Fair Values and Valuation Assumptions for Performance Units/Stocks Weighted average fair values and valuation assumptions used to value Performance Units during the years ended December 31, 2021, 2020 and 2019 were as follows:
 202120202019
Weighted Average Fair Value of Grants$95.16 $42.77 $79.98 
Expected Volatility53.80 %47.27 %29.20 %
Risk-Free Interest Rate0.59 %0.16 %1.51 %
Performance Unit and Performance Stock Transactions
The following table sets forth the Performance Unit transactions for the years ended December 31, 2021, 2020 and 2019 (units in thousands):
 202120202019
 Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Outstanding at January 1613 $88.38 598 $103.91 539 $116.96 
Granted222 95.16 172 42.77 172 79.98 
Granted for Performance Multiple (1)
19 113.81 66 119.10 72 80.64 
Released (2)
(175)113.06 (223)103.87 (185)110.65 
Forfeited— — — — — — 
Outstanding at December 31 (3)
679 (4)84.97 613 88.38 598 103.91 
(1)Upon completion of the Performance Period for the Performance Units granted in 2017, 2016 and 2015, a performance multiple of 125%, 150% and 200%, respectively, was applied to each of the grants resulting in additional grants of Performance Units in February 2021, 2020 and 2019.
(2)The total intrinsic value of Performance Units released during the years ended December 31, 2021, 2020 and 2019 was $13 million, $13 million and $15 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Units are released.
(3)The total intrinsic value of Performance Units outstanding at December 31, 2021, 2020 and 2019 was $60 million, $31 million and $50 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
(4)Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of zero and a maximum of 1,358 Performance Units could be outstanding.